Kalaris Therapeutics, Inc. (KLRS) — Financial Flexibility Index
Kalaris Therapeutics, Inc. (KLRS) has a Financial Flexibility Index of -0.32x as of March 2026. Free cash flow of $-13.35 Million (operating CF $-13.35 Million minus capex $0.00) represents 0% of total liabilities ($41.25 Million). Check Kalaris Therapeutics, Inc. (KLRS) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Kalaris Therapeutics, Inc. Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Kalaris Therapeutics, Inc. across 8 annual periods. See working capital to net assets of Kalaris Therapeutics, Inc. to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Kalaris Therapeutics, Inc. (2018–2025)
Year-by-year free cash flow to debt coverage for Kalaris Therapeutics, Inc.. For the full company profile including market capitalisation, see Kalaris Therapeutics, Inc. stock valuation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.00x | $-42.78 Million | $-42.98 Million | $42.92 Million | ▲ +92.3% |
| 2024 | -12.92x | $-67.70 Million | $-67.70 Million | $5.24 Million | ▼ -4321.5% |
| 2023 | -0.29x | $-14.13 Million | $-14.13 Million | $48.35 Million | ▼ -2.1% |
| 2022 | -0.29x | $-9.78 Million | $-9.78 Million | $34.17 Million | ▲ +83.5% |
| 2021 | -1.73x | $-106.29 Million | $-106.32 Million | $61.33 Million | ▲ +49.2% |
| 2020 | -3.41x | $-60.58 Million | $-60.81 Million | $17.76 Million | ▼ -206.4% |
| 2019 | -1.11x | $-19.82 Million | $-20.16 Million | $17.80 Million | ▼ -314.1% |
| 2018 | 0.52x | $1.94 Million | $1.94 Million | $3.74 Million | — |